Published in Urology on December 01, 2004
Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction - RELY-II. Can Urol Assoc J (2008) 1.72
Prostatic capsule- and nerve-sparing cystectomy in organ-confined bladder cancer: preliminary results. World J Surg (2005) 0.86
Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. World J Urol (2005) 0.80
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence. Clin Interv Aging (2009) 0.78
Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction. Int J Clin Pract (2009) 0.75
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol (2007) 4.37
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (2006) 3.23
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys (2010) 3.06
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A (2004) 2.53
EAU guidelines on penile curvature. Eur Urol (2012) 2.40
Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int (2012) 2.31
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics (2003) 2.17
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol (2007) 2.16
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection. J Urol (2010) 2.05
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin (2004) 2.03
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol (2007) 2.02
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol (2006) 2.02
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med (2008) 1.95
An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91
Development and external validation of an extended 10-core biopsy nomogram. Eur Urol (2006) 1.90
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology (2007) 1.83
Engaging men with penile cancer in qualitative research: reflections from an interview-based study. Nurse Res (2014) 1.72
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int (2007) 1.68
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol (2007) 1.65
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. Eur Urol (2007) 1.62
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med (2010) 1.60
Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun (2002) 1.53
The natural progression and regression of erectile dysfunction: follow-up results from the MMAS and MALES studies. J Sex Med (2011) 1.52
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease. J Sex Med (2013) 1.52
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study. Can Urol Assoc J (2009) 1.51
Gene therapy for erectile dysfunction: fact or fiction? Eur Urol (2006) 1.51
The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol (2007) 1.49
Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol (2011) 1.48
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol (2005) 1.45
Peripheral mechanisms of erectile dysfunction in a rat model of chronic cocaine use. Eur Urol (2007) 1.44
Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement. J Sex Med (2013) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Urology (2009) 1.42
Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol (2006) 1.41
Operative experience of urological trainees in the UK. BJU Int (2011) 1.41
Outcomes research: a methodologic review. Eur Urol (2006) 1.39
Management of ED under the "severe distress" criteria in the NHS: a real-life study. J Sex Med (2014) 1.39
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Thromb Haemost (2010) 1.39
Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl (2003) 1.37
Complication rates after hip or knee arthroplasty in morbidly obese patients. Clin Orthop Relat Res (2013) 1.37
A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol (2009) 1.35
Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol (2006) 1.34
Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl (2003) 1.32
A 4-year update on the safety of sildenafil citrate (Viagra). Urology (2002) 1.28
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol (2011) 1.26
Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol (2003) 1.22
Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med (2005) 1.21
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. BJU Int (2008) 1.18
Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med (2011) 1.14
Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol (2006) 1.13
Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl (2002) 1.13
Urinary biomarker profiling in transitional cell carcinoma. Int J Cancer (2006) 1.12
Arrestin binding to calmodulin: a direct interaction between two ubiquitous signaling proteins. J Mol Biol (2006) 1.11
Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. J Urol (2011) 1.11
An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat Rev Urol (2010) 1.10
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics (2006) 1.10
Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med (2005) 1.10
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care (2003) 1.10
Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int (2007) 1.09
Re: long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol (2012) 1.08
Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer (2004) 1.06
Penile size and the 'small penis syndrome'. BJU Int (2007) 1.06
Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options. Expert Opin Pharmacother (2011) 1.05
Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci U S A (2012) 1.04
Effect of needle size on cancer detection, pain, bleeding and infection in TRUS-guided prostate biopsies: A prospective trial. Can Urol Assoc J (2012) 1.03
A curriculum for sexual medicine? J Sex Med (2009) 1.03
Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. J Urol (2012) 1.02
The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int (2005) 1.00
Development and external validation of an extended repeat biopsy nomogram. J Urol (2007) 1.00
Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs (2006) 0.99
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty. Thromb Res (2012) 0.98
The hydrophilic-coated inflatable penile prosthesis: 1-year experience. J Sex Med (2004) 0.98
Managing the difficult penile prosthesis patient. J Sex Med (2013) 0.97
The pharmacological treatment of premature ejaculation. BJU Int (2008) 0.97
Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother (2010) 0.97
Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med (2012) 0.96
Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction. Expert Opin Investig Drugs (2010) 0.96
5-alpha reductase inhibitors and erectile dysfunction: the connection. J Sex Med (2008) 0.96
The penile implant for erectile dysfunction. J Sex Med (2004) 0.96
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res (2008) 0.96
Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor. J Pharmacol Exp Ther (2005) 0.95
Penile cancer: organ-sparing techniques. BJU Int (2014) 0.95
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur J Cancer (2007) 0.94
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.94
Age-related changes in prefrontal cortex activity are associated with behavioural deficits in both temporal and spatial context memory retrieval in older adults. Cortex (2009) 0.94
Uncialamycin, a new enediyne antibiotic. Org Lett (2005) 0.94
Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy. Urology (2008) 0.94
Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence. Eur Urol (2011) 0.94
Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease. Urology (2003) 0.93
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU Int (2006) 0.93
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec. Can J Urol (2005) 0.93